The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Label-Free Detection (LFD)-Global Market Insights and Sales Trends 2024
Synopsis
LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kinetic analysis, and others.
The global Label-Free Detection (LFD) market size is expected to reach US$ 1328.6 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Label-Free Detection (LFD) in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, CROs and Academic and Research Institutes,, are propelling Label-Free Detection (LFD) market. Biochemical Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell-based Assays segment is estimated at % CAGR for the next seven-year period.
LFD technology has replaced radioactive assay and enzyme-linked immunosorbent assay (ELISA). It helps study the interaction between drug and target.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Label-Free Detection (LFD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Label-Free Detection (LFD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Label-Free Detection (LFD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Label-Free Detection (LFD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Label-Free Detection (LFD) covered in this report include Bio-Rad Laboratories, GE Healthcare, Roche, Ametek, Attana, BiOptix, Corning, Juno Therapeutics and Pall, etc.
The global Label-Free Detection (LFD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
GE Healthcare
Roche
Ametek
Attana
BiOptix
Corning
Juno Therapeutics
Pall
SymCel
Global Label-Free Detection (LFD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Label-Free Detection (LFD) market, Segment by Type:
Biochemical Assays
Cell-based Assays
Global Label-Free Detection (LFD) market, by Application
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Label-Free Detection (LFD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
LFD technology is used in the process of drug discovery. The main use of LFD technology is kinetics and analysis during drug discovery. LFD technology is widely used for end-point screening and specificity testing. Some of the benefits of LFD technology include faster turnaround time, real-time kinetic analysis, and others.
The global Label-Free Detection (LFD) market size is expected to reach US$ 1328.6 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Label-Free Detection (LFD) in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, CROs and Academic and Research Institutes,, are propelling Label-Free Detection (LFD) market. Biochemical Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell-based Assays segment is estimated at % CAGR for the next seven-year period.
LFD technology has replaced radioactive assay and enzyme-linked immunosorbent assay (ELISA). It helps study the interaction between drug and target.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Label-Free Detection (LFD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Label-Free Detection (LFD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Label-Free Detection (LFD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Label-Free Detection (LFD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Label-Free Detection (LFD) covered in this report include Bio-Rad Laboratories, GE Healthcare, Roche, Ametek, Attana, BiOptix, Corning, Juno Therapeutics and Pall, etc.
The global Label-Free Detection (LFD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
GE Healthcare
Roche
Ametek
Attana
BiOptix
Corning
Juno Therapeutics
Pall
SymCel
Global Label-Free Detection (LFD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Label-Free Detection (LFD) market, Segment by Type:
Biochemical Assays
Cell-based Assays
Global Label-Free Detection (LFD) market, by Application
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Label-Free Detection (LFD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Label-Free Detection (LFD)
1.1 Label-Free Detection (LFD) Market Overview
1.1.1 Label-Free Detection (LFD) Product Scope
1.1.2 Label-Free Detection (LFD) Market Status and Outlook
1.2 Global Label-Free Detection (LFD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Label-Free Detection (LFD) Market Size by Region (2018-2029)
1.4 Global Label-Free Detection (LFD) Historic Market Size by Region (2018-2023)
1.5 Global Label-Free Detection (LFD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Label-Free Detection (LFD) Market Size (2018-2029)
1.6.1 North America Label-Free Detection (LFD) Market Size (2018-2029)
1.6.2 Europe Label-Free Detection (LFD) Market Size (2018-2029)
1.6.3 Asia-Pacific Label-Free Detection (LFD) Market Size (2018-2029)
1.6.4 Latin America Label-Free Detection (LFD) Market Size (2018-2029)
1.6.5 Middle East & Africa Label-Free Detection (LFD) Market Size (2018-2029)
2 Label-Free Detection (LFD) Market by Type
2.1 Introduction
2.1.1 Biochemical Assays
2.1.2 Cell-based Assays
2.2 Global Label-Free Detection (LFD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Label-Free Detection (LFD) Historic Market Size by Type (2018-2023)
2.2.2 Global Label-Free Detection (LFD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Label-Free Detection (LFD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Label-Free Detection (LFD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Label-Free Detection (LFD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Label-Free Detection (LFD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Label-Free Detection (LFD) Revenue Breakdown by Type (2018-2029)
3 Label-Free Detection (LFD) Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biotechnology Companies
3.1.2 CROs
3.1.3 Academic and Research Institutes
3.2 Global Label-Free Detection (LFD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Label-Free Detection (LFD) Historic Market Size by Application (2018-2023)
3.2.2 Global Label-Free Detection (LFD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Label-Free Detection (LFD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Label-Free Detection (LFD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Label-Free Detection (LFD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Label-Free Detection (LFD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Label-Free Detection (LFD) Revenue Breakdown by Application (2018-2029)
4 Label-Free Detection (LFD) Competition Analysis by Players
4.1 Global Label-Free Detection (LFD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Label-Free Detection (LFD) as of 2022)
4.3 Date of Key Players Enter into Label-Free Detection (LFD) Market
4.4 Global Top Players Label-Free Detection (LFD) Headquarters and Area Served
4.5 Key Players Label-Free Detection (LFD) Product Solution and Service
4.6 Competitive Status
4.6.1 Label-Free Detection (LFD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad Laboratories
5.1.1 Bio-Rad Laboratories Profile
5.1.2 Bio-Rad Laboratories Main Business
5.1.3 Bio-Rad Laboratories Label-Free Detection (LFD) Products, Services and Solutions
5.1.4 Bio-Rad Laboratories Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Laboratories Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Label-Free Detection (LFD) Products, Services and Solutions
5.2.4 GE Healthcare Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Label-Free Detection (LFD) Products, Services and Solutions
5.3.4 Roche Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.3.5 Ametek Recent Developments
5.4 Ametek
5.4.1 Ametek Profile
5.4.2 Ametek Main Business
5.4.3 Ametek Label-Free Detection (LFD) Products, Services and Solutions
5.4.4 Ametek Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.4.5 Ametek Recent Developments
5.5 Attana
5.5.1 Attana Profile
5.5.2 Attana Main Business
5.5.3 Attana Label-Free Detection (LFD) Products, Services and Solutions
5.5.4 Attana Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.5.5 Attana Recent Developments
5.6 BiOptix
5.6.1 BiOptix Profile
5.6.2 BiOptix Main Business
5.6.3 BiOptix Label-Free Detection (LFD) Products, Services and Solutions
5.6.4 BiOptix Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.6.5 BiOptix Recent Developments
5.7 Corning
5.7.1 Corning Profile
5.7.2 Corning Main Business
5.7.3 Corning Label-Free Detection (LFD) Products, Services and Solutions
5.7.4 Corning Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.7.5 Corning Recent Developments
5.8 Juno Therapeutics
5.8.1 Juno Therapeutics Profile
5.8.2 Juno Therapeutics Main Business
5.8.3 Juno Therapeutics Label-Free Detection (LFD) Products, Services and Solutions
5.8.4 Juno Therapeutics Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.8.5 Juno Therapeutics Recent Developments
5.9 Pall
5.9.1 Pall Profile
5.9.2 Pall Main Business
5.9.3 Pall Label-Free Detection (LFD) Products, Services and Solutions
5.9.4 Pall Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.9.5 Pall Recent Developments
5.10 SymCel
5.10.1 SymCel Profile
5.10.2 SymCel Main Business
5.10.3 SymCel Label-Free Detection (LFD) Products, Services and Solutions
5.10.4 SymCel Label-Free Detection (LFD) Revenue (US$ Million) & (2018-2023)
5.10.5 SymCel Recent Developments
6 North America
6.1 North America Label-Free Detection (LFD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Label-Free Detection (LFD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Label-Free Detection (LFD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Label-Free Detection (LFD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Label-Free Detection (LFD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Label-Free Detection (LFD) Market Dynamics
11.1 Label-Free Detection (LFD) Industry Trends
11.2 Label-Free Detection (LFD) Market Drivers
11.3 Label-Free Detection (LFD) Market Challenges
11.4 Label-Free Detection (LFD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
